Capital raised by Latigo Biotherapeutics
1 Form D filing · first filed Jan 2025 · Thousand Oaks, CA
Chief Financial Officer
Signatory on Latigo Biotherapeutics's Form D filings · $50.0M raised across 1
Tim Lugo is on file as Chief Financial Officer at Latigo Biotherapeutics in Thousand Oaks, CA. Latigo Biotherapeutics has 1 Form D filing on record, $50.0M raised in total. Tim Lugo appears as a signatory on the company's filings.
No other people are on file at Latigo Biotherapeutics. Form D filings only name the signatory and the company's executive officers.
LTG-001 is Latigo Biotherapeutics' lead candidate that aims to provide effective non-opioid pain relief. Successfully navigating Phase 1 clinical trials, it addresses the root causes of pain without the associated risks of addiction linked to opioid medications.
